Total Valuation
Sumitomo Dainippon Pharma Co has a market cap or net worth of $3.58B. The enterprise value is $737.89K.
Market Cap$3.58B
Enterprise Value$737.89K
Share Statistics
Sumitomo Dainippon Pharma Co has 449,204,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding449,204,560
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sumitomo Dainippon Pharma Co’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 4.06%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.06%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee127.71M
Profits Per Employee7.57M
Employee Count3,123
Asset Turnover0.54
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Sumitomo Dainippon Pharma Co is 4.5. Sumitomo Dainippon Pharma Co’s PEG ratio is 0.02.
PE Ratio4.5
PS Ratio1.82
PB Ratio2.82
Price to Fair Value1.71
Price to FCF12.29
Price to Operating Cash Flow―
PEG Ratio0.02
Income Statement
In the last 12 months, Sumitomo Dainippon Pharma Co had revenue of 398.83B and earned 23.63B in profits. Earnings per share was 59.49.
Revenue398.83B
Gross Profit225.38B
Operating Income22.42B
Pretax Income17.61B
Net Income23.63B
EBITDA51.73B
Earnings Per Share (EPS)59.49
Cash Flow
In the last 12 months, operating cash flow was 29.97B and capital expenditures -6.96B, giving a free cash flow of 23.02B billion.
Operating Cash Flow29.97B
Free Cash Flow23.02B
Free Cash Flow per Share51.24
Dividends & Yields
Sumitomo Dainippon Pharma Co pays an annual dividend of $0.053, resulting in a dividend yield of ―
Dividend Per Share$0.053
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change-4.90%
50-Day Moving Average8.84
200-Day Moving Average12.30
Relative Strength Index (RSI)38.20
Average Volume (3m)230.00
Important Dates
Sumitomo Dainippon Pharma Co upcoming earnings date is Nov 4, 2026, TBA (Confirmed).
Last Earnings DateJul 31, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date―
Financial Position
Sumitomo Dainippon Pharma Co as a current ratio of 1.05, with Debt / Equity ratio of ―
Current Ratio1.05
Quick Ratio0.66
Debt to Market Cap1.05
Net Debt to EBITDA5.63
Interest Coverage Ratio2.62
Taxes
In the past 12 months, Sumitomo Dainippon Pharma Co has paid -6.02B in taxes.
Income Tax-6.02B
Effective Tax Rate-0.34
Enterprise Valuation
Sumitomo Dainippon Pharma Co EV to EBITDA ratio is 11.23, with an EV/FCF ratio of 72.58.
EV to Sales1.46
EV to EBITDA11.23
EV to Free Cash Flow72.58
EV to Operating Cash Flow35.20
Balance Sheet
Sumitomo Dainippon Pharma Co has $38.49B in cash and marketable securities with $160.66B in debt, giving a net cash position of -$224.36B billion.
Cash & Marketable Securities$38.49B
Total Debt$160.66B
Net Cash-$224.36B
Net Cash Per Share-$499.46
Tangible Book Value Per Share-$504.51
Margins
Gross margin is ―, with operating margin of 5.62%, and net profit margin of 5.93%.
Gross Margin―
Operating Margin5.62%
Pretax Margin4.42%
Net Profit Margin5.93%
EBITDA Margin12.97%
EBIT Margin6.56%
Analyst Forecast
The average price target for Sumitomo Dainippon Pharma Co is $9.53, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$9.53
Price Target Upside21.53% Upside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast10.59%
EPS Growth Forecast512.90%